Taylor Schreiber
Founder bei SHATTUCK LABS, INC.
Vermögen: 25 Mio $ am 31.03.2024
Profil
Taylor H.
Schreiber is the founder.
He founded Shattuck Labs, Inc. in 2016 and currently holds the title of Chief Executive Officer & Director.
He also held the position of Director at Pelican Therapeutics, Inc. from 2011 to 2017.
Additionally, he served as the Chief Scientific Officer at Scorpius Holdings, Inc. from 2015 to 2016.
Dr. Schreiber has an undergraduate degree from Bucknell University and a doctorate from The University of Miami Leonard M.
Miller School of Medicine.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
SHATTUCK LABS, INC.
5,81% | 12.01.2024 | 2 757 686 ( 5,81% ) | 25 Mio $ | 31.03.2024 |
Aktive Positionen von Taylor Schreiber
| Unternehmen | Position | Beginn |
|---|---|---|
| SHATTUCK LABS, INC. | Founder | 01.01.2016 |
Ehemalige bekannte Positionen von Taylor Schreiber
| Unternehmen | Position | Ende |
|---|---|---|
Pelican Therapeutics, Inc.
 Pelican Therapeutics, Inc. Hospital/Nursing ManagementHealth Services Pelican Therapeutics, Inc. operates as an immuno-oncology company. It develops biological agents that represents the next generation of tumor necrosis factor (TNF) based immunotherapy. The company was founded by Jeffrey Wolf and Josiah C. Hornblower on March 6, 2017 and is headquartered in Dallas, TX. | Director/Board Member | 01.01.2017 |
| SCORPIUS HOLDINGS, INC. | Chief Tech/Sci/R&D Officer | 31.12.2016 |
| SCORPIUS HOLDINGS, INC. | Chief Tech/Sci/R&D Officer | - |
Ausbildung von Taylor Schreiber
| Bucknell University | Undergraduate Degree |
| The University of Miami Leonard M. Miller School of Medicine | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| SCORPIUS HOLDINGS, INC. | Health Technology |
| SHATTUCK LABS, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Pelican Therapeutics, Inc.
Pelican Therapeutics, Inc. Hospital/Nursing ManagementHealth Services Pelican Therapeutics, Inc. operates as an immuno-oncology company. It develops biological agents that represents the next generation of tumor necrosis factor (TNF) based immunotherapy. The company was founded by Jeffrey Wolf and Josiah C. Hornblower on March 6, 2017 and is headquartered in Dallas, TX. | Health Services |
